Janine Bestall News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A unique study in patients with renal cell carcinoma on tyrosine kinase inhibitors (TKIs) shows that taking a break from the drugs is feasible and cost-effective.

United statesUnited kingdomJenny hewisonMoshe ornsteinJanine bestallJanet brownLeeds university school of medicineUnited kingdom national institute for healthUk national institute for healthUniversity of leedsCare researchUniversity of sheffieldNational instituteMedscape medicalLeeds university schoolTreatment strategies